Mode
Text Size
Log in / Sign up

Cross-sectional review links antecedent autonomic symptoms to burden in SCAD survivors

Cross-sectional review links antecedent autonomic symptoms to burden in SCAD survivors
Photo by Brett Jordan / Unsplash
Key Takeaway
Note that antecedent autonomic symptoms predict burden in SCAD survivors but not recurrence.

This cross-sectional review analyzed data from 227 survivors of spontaneous coronary artery dissection (SCAD) across multiple countries. The study assessed the relationship between antecedent autonomic symptoms and contemporary autonomic symptom burden, health-related quality of life, and recurrence risk. The primary outcome was contemporary autonomic symptom burden, while secondary outcomes included health-related quality of life, cardiac and extra-cardiac symptoms, and SCAD recurrence.

History of antecedent autonomic symptoms was identified as the strongest independent predictor of contemporary autonomic symptom burden, with a beta coefficient of 0.514 (P <0.001). Furthermore, greater autonomic symptom burden independently predicted lower EQ-5D health utility (beta=-0.150, P=0.029) and was associated with ASI-3 physical concerns (beta=-0.232, P <0.001). However, autonomic symptoms were not associated with ASI-3 social concerns or SCAD recurrence, as these associations were not reported or showed no association.

The follow-up duration was a median of 3 (1-5) years after the index SCAD event. Because this is a cross-sectional study, the authors caution that causality cannot be inferred from these associations. Additionally, the predictive value of antecedent symptoms should not be overstated without longitudinal data, and clinical outcomes should not be assumed from surrogate measures like EQ-5D without explicit linkage.

Study Details

EvidenceLevel 5
PublishedApr 2026
View Original Abstract ↓
Introduction: Spontaneous coronary artery dissection (SCAD) is frequently accompanied by persistent symptoms of unknown pathogenesis after the index event. Autonomic dysfunction is a plausible mechanism for these but has not been systematically characterized. We quantified antecedent and contemporary autonomic symptoms in survivors of SCAD and examined their associations with cardiac and extra-cardiac symptoms and health-related quality of life. Methods: This cross-sectional study recruited 227 volunteers from multiple countries with a self-reported history of SCAD. Participants completed validated patient-reported measures, including the Composite Autonomic Symptom Score-31 (COMPASS-31), Anxiety Sensitivity Index-3 (ASI-3), and EuroQol-5 Dimension-5L (EQ-5D-5L). They also completed an internally derived retrospective autonomic predisposition score assessing symptoms during adolescence and early adulthood. Results: Participants were predominantly female (97.8%), median age 53 (47-58) years, and were surveyed a median of 3 (1-5) years after their index SCAD event. 21.6% reported SCAD recurrence. Moderate autonomic symptom burden (COMPASS-31 20) was present in 56.4% and severe burden (40) in 16.3%. History of antecedent autonomic symptoms was the strongest independent predictor of contemporary autonomic symptom burden after adjustment for demographic and clinical covariates (=0.514; P <0.001). Greater autonomic symptom burden independently predicted lower EQ-5D health utility (=0.150; P=0.029) and was associated with the ASI-3 physical concerns (=0.232; P <0.001), but not social concerns domain. Autonomic symptoms were not associated with SCAD recurrence. Conclusion: Symptoms of autonomic dysregulation are common in survivors of SCAD and are associated with reduced quality of life. Their association with antecedent dysautonomic features during adolescence and early adulthood suggests a longstanding predisposition, the significance of which warrants further evaluation.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.